Stop Taking Nan Bao!

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

If you are one of those who consumes ‘Nan Bao’ capsules, be aware that the Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has released a statement that all sellers and distributors of this traditional supplement to stop all sales and distribution as it is against the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984.

These capsules are found to contain sildenafil and tadalafil, both which are ingredients used medically to treat erectile dysfunction. These medication can only be obtained via a prescription from a doctor. Supplements containing these are not allowed to be classified as traditional.

“The use of sildenafil and tadalafil without a doctor’s advice can cause serious adverse effects such as impairment of vision and hearing, low blood pressure, and effects to the cardiovascular systems such as stroke and heart attack.” The misuse of these medication can prove to be dangerous especially those who consume medication containing nitrates.

If you had tried taking or is currently taking “Nan Bao” supplements, visit your nearest doctor or pharmacist if you experience any discomfort.

Related

Many of you might have read posts or articles about the issues faced by provisionally registered pharmacists (PRP) securing a place in the government sector after their 1-year training. This came about after the posting results of the first batch of contract Fully Registered Pharmacists (FRPs) in the public sector was released. Many have expressed…

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast.   What? The critical allowance, or more commonly known as Bayaran Insentif Perkhidmatan Kritikal (BIPK) was a fund started in 1992 for jobs which fulfilled 2 criteria: 1) The job has low remuneration 2)…

Recall of Losartan

Last updated on

On early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to…

Remdesivir: Yay or Nay?

Last updated on
Since our last article on Remdesivir, much has been discovered about its potential clinical application via several high-profile clinical trials. On 15th October 2020, we first heard of less-than-promising results from the WHO SOLIDARITY trial that Remdesivir has “little to no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation, and duration...

This Clinical Pharmacokinetics Pharmacy Handbook 2nd Edition contains the updated information and practice in Clinical Pharmacokinetics Pharmacy. Examples of real case scenario are included in each of the chapter for a better understanding in calculation concept and application. The handbook can be downloaded here.

At the Malaysian Society of Hypertension’s (MSH) 15th Annual Scientific Meeting, Professor Abdul Rashid Abdul Rahman, the Chairman Working Group on 5th Malaysian Hypertension Clinical Practice Guidelines (CPG) 2018 said that many updates can be expected from the new CPG. One of these new recommendations is the preference for validated electronic blood pressure (BP) sets over mercury sphygmomanometers....

Others

[UPDATE] As of 8/12/2020 The Light at the End of the Tunnel On 8 December, the United Kingdom has been the very first nation to begin vaccinating its citizens. 90 year-old Margaret Keenan was the first Briton to receive the Pfizer/BioNTech vaccine. The UK has also placed an order for the Moderna vaccines for a...

MPS Ordinary, Postgraduate, Associate Members (with Sub Paid Up Year 2018), Life and Fellow Members are automatically enrolled into the system.  No further action is require to access the system. MPS Members will also be able to access the Academy of Pharmacy E-Learning Programme website (www.acadpharm.org.my) besides the CPD-Online website (www.mps.org.my/cpdonline) with the same login…

  It has been a somber Chinese New Year - no, not just because of less ang paus - but because of the novel coronavirus that still continues to propagate across the entire globe. Having been declared a global health emergency, the virus has infected over 20 thousand people and proven fatal to 427.  Today,...
Remdesivir in Malaysia As everyone eagerly awaits results from clinical trials regarding treatment and vaccination option(s) for COVID-19, a possible “knight in shining armour” emerges: Remdesivir. Remde-saviour? Currently, the medication is undergoing 6 separate clinical trials for COVID-19: 2 initiated by Gilead (the manufacturer) (moderate & severe manifestations) 2 by health authorities in China (mild/moderate...

  With new digital technologies growing increasingly involved in contemporary healthcare, an upcoming symposium aims to place the implications for patient welfare at the centre of the discussion. This October, the third edition of the Malaysian Innovative Healthcare Symposium 2018 (MIHS 2018) will bring together healthcare professionals to explore the potential of current and upcoming…

Malaysia ranked #1 on Healthcare Index Score

Last updated on

In the beginning of 2019, lifestyle and living website International Living published its list of the World’s Best Place to Retire in 2019. The list was started 29 years ago and is still being updated every single year since then. With a huge team which covers 5 continents, its research and methodologies are second to…